Related references
Note: Only part of the references are listed.Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies
Scott Davis et al.
TRANSPLANTATION (2020)
Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection
Masayuki Tasaki et al.
TRANSPLANTATION PROCEEDINGS (2019)
OPTN/SRTR 2017 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients
Edmund Huang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Precision Transplant Medicine: Biomarkers to the Rescue
Maarten Naesens et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies
R. A. Bray et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis
Susan S. Wan et al.
TRANSPLANTATION (2018)
Review: The transcripts associated with organ allograft rejection
Philip F. Halloran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation
Scott Davis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Urinary MicroRNA as Biomarker in Renal Transplantation
M. van de Vrie et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss
Denis Viglietti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients
Jean Kwun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
Chris Wiebe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Cell-Free DNA and Active Rejection in Kidney Allografts
Roy D. Bloom et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody
Manuel A. Moreno Gonzales et al.
TRANSPLANTATION (2017)
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function
A. B. Adams et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
J. Choi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients
C. Wehmeier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss
C. A. Schinstock et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
OPTN/SRTR 2015 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
R. A. Montgomery et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
O. O. Adebiyi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
D. Viglietti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta-Analysis
D. Sawinski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial
Benedicte Sautenet et al.
TRANSPLANTATION (2016)
Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
L. D. Cornell et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection
B. J. Orandi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts
Alexandre Loupy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA-Incompatible Kidney Transplantation
Babak J. Orandi et al.
TRANSPLANTATION (2014)
Antibody-mediated vascular rejection of kidney allografts: a population-based study
Carmen Lefaucheur et al.
LANCET (2013)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
J. Sellares et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Proteasome inhibitor-based therapy for antibody-mediated rejection
R. Carlin Walsh et al.
KIDNEY INTERNATIONAL (2012)
Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
Johannes Waiser et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients-A Systematic Review
Darren M. Roberts et al.
TRANSPLANTATION (2012)
Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA)
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients
J. M. Lorenzen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Desensitization Protocols and Their Outcome
Kwaku Marfo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation
Stuart M. Flechner et al.
TRANSPLANTATION (2010)
Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
C. Lefaucheur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody-Mediated Damage Despite Lack of C4d Staining
Banu Sis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
G. Einecke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Kai-Uwe Eckardt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study
D. Rush et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Immunosuppression and immune monitoring after renal transplantation
MS Zand
SEMINARS IN DIALYSIS (2005)
Share Paper
